The trademark EPIFIN was filed by Laboratoires Medgen, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on February 23, 2022, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on May 23, 2022 by LEK farmacevtska druzba d.d. on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English The second opposition filed on May 23, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 11, 2022.
The Opposition with reference B 003171636 was refused according to Article 8(1)(b) EUTMR with decision issued on June 20, 2023 by the EUIPO.